INTEGRA's automated solutions optimize CRISPR workflows, enhancing gene editing efficiency and accelerating the path to ...
Earlier this year, a baby was successfully treated with a new CRISPR therapy to correct a rare genetic disorder. Researchers at Berkeley’s Innovative Genomics Institute — founded by Professor Jennifer ...
Gene-editing techniques such as CRISPR-Cas9 have many uses in the area of food and agriculture. They can combat persistent drought and disease, and improve the colour and nutritional content of food ...
Forbes contributors publish independent expert analyses and insights. Sai writes about healthcare, innovation and technology. This voice experience is generated by AI. Learn more. This voice ...
CRISPR-Cas 9 is a gene-editing tool that made it possible to rewrite any organism's genetic code and tackle genetic diseases more effectively. Known as genetic scissors, CRISPR identifies a DNA ...
A major medical milestone took place in May 2025, when doctors at the Children’s Hospital of Philadelphia used CRISPR-based gene editing to treat a child with a rare genetic disorder. Unlike earlier ...
CRISPR has taken the bioengineering world by storm since its first introduction. From treating sickle cell diseases to creating disease-resistant crops, the technology continues to boast success on ...
I have been covering the Swiss-based gene therapy specialist drug developer CRISPR Therapeutics AG (CRSP) in notes for Seeking Alpha since my first post on the company all the way back in May 2021, ...
A new engineered gene-editing system, proven in bacteria and showing promise for use in plants, animals and humans, addresses ...
Scientists at the San Raffaele Telethon Institute for Gene Therapy (SR-Tiget), Milan, have found that gene editing using CRISPR-Cas9 in combination with AAV6 vectors can trigger inflammatory and ...
A Cleveland Clinic first-in-human clinical trial has shown that a one-time infusion of a gene-editing therapy using CRISPR-Cas9 was effective and safe in reducing LDL ("bad") cholesterol and ...